Potential COVID-19 drug azithromycin may increase risk for cardiac events

Azithromycin -- a commonly-prescribed antibiotic -- also is being investigated as a potential treatment for COVID-19. Researchers have found that azithromycin by itself is not associated with an increase in cardiac events; however, if the drug is taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increased.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200916113422.htm